News from us and our partners
Tags
Topics
0 results
Calliditas announces primary endpoint successfully met in Phase 3 NefIgArd trial evaluating Nefecon® in IgA nephropathy
Enthera Pharmaceuticals initiates Phase 1 clinical trial with lead candidate Ent001
Noema Pharma, founded by Sofinnova Partners, raises CHF 103 million (USD112million) in Series B financing
Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors
Chroma Medicine secures $135M in Series B financing to advance breakthrough epigenetic editing technology and expand pipeline of durable precision genomic medicines
Acquisition of CinCor Pharma complete
Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)
Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
Elicit Plant validates on a large scale the performance of its BEST-a product for corn that reduces crops’ water consumption and addresses the challenges of climate change
Prometheus Materials secures multiple ASTM certifications, bringing initial production into full-swing
RefleXion receives FDA clearance for SCINTIX biology-guided radiotherapy; cutting-edge treatment applicable for early and late-stage cancers
Prof. Jacques Séguin, renowned inventor of CoreValve, joins Endoron Medical as Chairman of the Board
AFYREN chooses Thailand for its second biobased organic acids plant, entering a partnership project with Mitr Phol, a global leader in the sugar industry
Amolyt Pharma announces research agreement and licensing option with XOMA
Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke